Had Hypersensitivity Reaction to Ziagen, Abacavir, or Trizivir?

Last week, “About AIDS” addressed a local research project involving HIV medication side effects, in general. The same group, Central Texas Clinical Research, is also doing another data-gathering trial, but with a specific drug and a specific type of reaction. CTCR wants to interview HIV-infected people who have had hypersensitivity reactions after taking Abacavir. (Abacavir is also known by its brand name, Ziagen, and is one of the three drugs in Trizivir. It doesn’t matter which form someone has taken.) If you have had a hypersensitivity reaction, you could participate in research to determine what genetic markers cause it to occur.

This trial consists of just two visits. The first is a screening visit, where a medical history is taken, including information about the reaction you experienced. That information is submitted to the sponsor for approval to participate. After approval, blood will be drawn at a second visit.

Participants will not be receiving any experimental drugs in this study. Only past medical information and a blood draw are required. If you are interested in helping with this research, please contact Chris Miklos at Central Texas Clinical Research, 512/480-9660.

Sandy Bartlett

Community Education Coordinator, AIDS Services of Austin

This article appears in May 17 • 2002.

A note to readers: Bold and uncensored, The Austin Chronicle has been Austin’s independent news source for over 40 years, expressing the community’s political and environmental concerns and supporting its active cultural scene. Now more than ever, we need your support to continue supplying Austin with independent, free press. If real news is important to you, please consider making a donation of $5, $10 or whatever you can afford, to help keep our journalism on stands.

SUPPORT US